Feedback form for people, families and whānau with lived experiences

Have your say on our proposal to fund treatments for stage III and IV melanoma

About this form

Please note:

You cannot save your progress.
The form does not register text formatting, such as bold or hyperlinks.
There is no character limit on any field.
You will receive an email with a summary of your feedback when you submit the form.
Unless stated otherwise, all questions are optional.

Do you have any comments or feedback you would like to provide about the proposal?

Do you have any feedback on the proposed eligibility criteria?

Do you think the criteria will ensure we target the group/s most likely to benefit and/or with the greatest health need?

Do you have any feedback on the proposal to fund both oral treatments and one needing to be given by an infusion in hospital or community?

Do you have any experiences that you would like to share that are relevant to Pharmac’s consideration of this proposal?

About you

Your name

Your email address

This field is mandatory, if you don't want to give your email address, just leave the placeholder text in this box.

Are you submitting this response on behalf of an organisation?

Yes

Your feedback may be shared

When you give feedback on a consultation, your feedback becomes official information that Pharmac holds. Pharmac has legal responsibilities for how we manage this official information, under laws such as the Official Information Act and Privacy Act.

Pharmac may receive a request from people for official information, which could include your feedback. Legally, Pharmac must consider whether your feedback should be released.

We will consider your views when assessing whether the feedback has to be released.

If your feedback is proposed for release, then Pharmac will contact you, unless there is a legal reason that we can't.

Note that Pharmac collects and holds your information in line with our Privacy Statement.

Please tell us if there is anything in your feedback that you would prefer was not released.